Streamline Health Solutions (NASDAQ:STRM) Earns Sell Rating from Analysts at StockNews.com

Equities research analysts at StockNews.com assumed coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a note issued to investors on Saturday. The firm set a “sell” rating on the stock.

Separately, Craig Hallum raised Streamline Health Solutions to a “strong-buy” rating in a research report on Thursday, September 5th.

Streamline Health Solutions Stock Up 3.1 %

Shares of Streamline Health Solutions stock opened at $2.30 on Friday. The company has a market capitalization of $9.71 million, a P/E ratio of -0.46 and a beta of 1.60. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.61 and a quick ratio of 0.61. The business has a 50-day moving average of $3.93 and a two-hundred day moving average of $5.60. Streamline Health Solutions has a 1 year low of $1.85 and a 1 year high of $9.75.

Streamline Health Solutions (NASDAQ:STRM) last posted its quarterly earnings data on Wednesday, September 11th. The company reported ($0.75) earnings per share for the quarter, missing the consensus estimate of ($0.60) by ($0.15). Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%. The firm had revenue of $4.48 million for the quarter.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.